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The hypothalamic-pituitary-adrenal axis is the primary neuroendocrine system 37 
activated to re-establish homeostasis during periods of stress, including critical illness and 38 
major surgery. During critical illness, evidence suggests that locally induced inflammation of 39 
the adrenal gland could facilitate immune-adrenal cross-talk and, in turn, modulate cortisol 40 
secretion. It has been hypothesized that immune cells are necessary to mediate the effect of 41 
inflammatory stimuli on the steroidogenic pathway that has been observed in vivo. To test 42 
this hypothesis, we developed and characterized a trans-well co-culture model of THP1 43 
(human monocytic cell)-derived macrophages and ATC7 murine zona fasciculata 44 
adrenocortical cells. We found that co-culture of ATC7 and THP1 cells results in a 45 
significant increase in the basal levels of IL-6 mRNA in ATC7 cells, and this effect was 46 
potentiated by treatment with LPS. Addition of LPS to co-cultures of ATC7 and THP1 47 
significantly decreased the expression of key adrenal steroidogenic enzymes (including StAR 48 
and DAX-1), and this was also found in ATC7 cells trea ed with pro-inflammatory cytokines. 49 
Moreover, 24-hour treatment with the synthetic glucocorticoid dexamethasone prevented the 50 
effects of LPS stimulation on IL-6, StAR and DAX-1 mRNA in ATC7 cells co-cultured with 51 
THP1 cells. Our data suggest that the expression of IL-6 and steroidogenic genes in response 52 
to LPS depends on the activation of intra-adrenal immune cells. Moreover, we also show that 53 
the effects of LPS can be modulated by glucocorticoids in a time- and dose-dependent 54 
manner with potential implications for clinical practice. 55 














The acute stress response in man includes activation of the sympathetic nervous 59 
system, the hypothalamic-pituitary-adrenal (HPA) axis, as well as immunological and 60 
haematological responses (Desborough 2000). Internal and external stressors are integrated 61 
through the brain stem and limbic areas, projecting o the hypothalamic paraventricular 62 
nucleus, which innervates the median eminence to releas  CRH into the portal circulation and 63 
thence corticotroph cells of the anterior pituitary. These cells release ACTH into the systemic 64 
circulation which, in turn, activates both the production and release of glucocorticoids 65 
(corticosterone in rodents and predominantly cortisl n humans cortisol) from the zona 66 
fasciculata of the adrenal gland, which is vital for homeostatic regulation (Spiga et al. 2014).  67 
 68 
In the adrenal cortex, ACTH binds to the melanocortin type-2 receptor (MC2R), 69 
leading to activation of the protein kinase A (PKA) pathway, which in turn results in 70 
activation of steroidogenic gene expression, via non-genomic and genomic pathways. 71 
(reviewed in (Miller & Auchus 2011)). While the non-genomic pathway includes the 72 
phosphorylation and activation, of steroidogenic proteins including the rate-limiting 73 
steroidogenic acute regulatory protein (StAR) (Stocco & Clark 1996; Arakane t al. 1997; 74 
Spiga et al. 2017), the genomic pathway regulates the transcription of steroidogenic proteins 75 
and its transcriptional regulators. This includes transcription of steroidogenic proteins such as 76 
StAR, MC2R, melanocortin receptor accessory protein (MRAP, a protein that regulates 77 
MC2R expression (Metherell et al. 2005) as well as the orphan nuclear receptor – 78 
steroidogenic factor (SF-1) (Sugawara et al. 1996) and the transcriptional inhibitor DAX-1 79 
(the dosage-sensitive sex reversal, adrenal hypoplasia congenital critical region on the X 80 











secretion is regulated  by a negative feedback mechanisms wherbay cortisol exert inhibitory 82 
effects at the pituitary and hypothalamic levels.  83 
 84 
According to this “traditional” model, any increase in ACTH secretion in response to 85 
acute stress will result in concomitant increased cortisol. However, during surgery and critical 86 
illness, a so-called “ACTH-cortisol dissociation” occurs (Gibbison & Spiga 2014; Boonen t 87 
al. 2015). Systemic administration of LPS in the rat results in a similar pattern: an initial rise 88 
in ACTH and corticosterone, followed by a return of ACTH to basal levels within 6 hours 89 
while the corticosterone remained elevated for a further 4 hour (Gibbison & Spiga 2014). The 90 
mechanisms behind these findings are a matter of debate and studies have suggested altered 91 
cortisol metabolism (Boonen et al. 2013), increased sensitivity of the adrenal cortex to ACTH 92 
(Gibbison et al. 2015) and local, adrenal “tissue” mechanisms that could involve the cellular 93 
interaction between the adrenal cells and the surrounding immune cells (Boonen et al. 2015). 94 
This cross-talk can occur via cytokines produced by adrenal cells themselves or by the 95 
neighbouring immune cells to regulate steroidogenesis (Bornstein et al. 2004a). The above 96 
hypotheses are supported by several studies. Lipopolysaccharide-induced systemic 97 
inflammation is accompanied by infiltration of leukocytes in the adrenal gland of rats 98 
(Kanczkowski et al. 2013a). Furthermore, in a mice model of sepsis-induce  by caecal 99 
ligation and puncture, the non-survivor mice have a significant increase of interleukin-6 (IL-100 
6), interleukin-1β (IL-1β), and tumour necrosis factor-α (TNFα) in adrenal protein extracts 101 
(Jennewein et al. 2016). Local modulation of the adrenocortical cell function can also occur 102 
directly, for example, via the toll-like receptor (TLR), or via circulating cytokines activating 103 
cytokine receptors, both of which are expressed in adrenocortical cells (Bornstein et al. 104 
2004b). However, it remains unclear if the plasma leve  of immune-derived cytokines is high 105 












locally within the adrenal gland (Ehrhart-Bornstein t al. 1998). Adrenal cells do produce a 107 
variety of cytokines such as IL-1, interferon-gamma inducing factor (IGIF), IL-6 and TNFα 108 
(Judd 1997; Bornstein et al. 2004a), and steroidogenesis is influenced directly by IL-1α, IL-109 
1β, interleukin IL-2, IL-6, TNFα, interferon-alpha (IFNα) both in vitro (Ehrhart-Bornstein et 110 
al. 1998) and in vivo (Spiga et al. 2020). Furthermore, a previous study using primary 111 
cultures of human adrenocortical cells co-cultured with human monocytes has shown a 112 
significant increase in cortisol production by the adrenal cells. In this study, the monocyte 113 
induced cortisol increase was much higher than that resulting from IL-1 treatment alone 114 
(Whitcomb et al. 1988).  115 
 116 
The current study describes a novel co-culture model f adrenocortical tumour cell 117 
lines murine ATC7 cells, with complete zona fasciculata (ZF) cell phenotype (Ragazzon et 118 
al. 2006; Hazell et al. 2019) and macrophages derived from THP1 monocytes (a human 119 
monocytic cell line derived from an acute monocytic leukaemia patient) (Tsuchiya et al. 120 
1980). Using this model, we explored the effects of an immunological stimulus 121 
(lipopolysaccharide, LPS) on the expression of the pro-inflammatory cytokine IL-6 as well as 122 
the expression of genes involved in steroidogenesis in ATC7 cells, both in basal conditions 123 
and under ACTH stimulation. Since synthetic glucocorti ids are still widely used in clinical 124 
practice to modulate the immune and adrenal response to acute stress observed during sepsis 125 
or surgery and their efficacy and mechanism of action remain a matter of intense debate 126 
(Fudulu et al. 2018), we also investigated the temporal effects of glucocorticoid treatment on 127 
the ATC7 cell responses to LPS. 128 
 129 
Material and methods 130 
 131 












Murine adrenocortical tumour ATC7 cells (a kind gift from Dr Pierre Val, Université 134 
Clermont Auvergne, Clermont-Ferrand, France), were cultured as previously described 135 
(Hazell et al. 2019). Human monocytic THP1 cells were purchased from Sigma (Sigma, 136 
Gillingham, UK). The reason behind the use of human macrophagic cells is that the 137 
difference in the species in the two cell types would allow us to measure specifically adrenal 138 
(murine) or macrophagic (human) cytokines expression. The methods of the co-culture 139 
experiments are summarised in figure 1. THP1 cells were cultured in suspension in 75cm2 140 
tissue-culture flasks in DMEM at 37°C in a 5%CO2-95% air atmosphere. The medium was 141 
supplemented with 20% horse serum penicillin (100U/ml) and streptomycin (100ug/ml). 142 
Cells were passaged every 3-4 days, and culture media changed every two days. 143 
Differentiation of THP1 cells was achieved by resuspending THP1 cells in medium 144 
containing 100nM PMA (Sigma) in 6 wells plate polycarbonate cell culture inserts (TC 145 
inserts, Sarsted, Nümbrecht, Germany). Cells were lft to differentiate for 72 hours then 146 
washed twice with 1x PBS (phosphate-buffered saline, pH 7.4, ThermoFisher, Waltham, MA 147 
USA). The insert containing THP1 cells was then trasferred into a six wells plate containing 148 
ATC7 cells and incubated in serum-free media (DMEM/F12/0.1% BSA). The ratio of ATC7 149 
cells co-incubated with THP1 cells was kept at 1:2 for all experiments except on the ratio 150 
experiment in which different ratio ATC7: THP1 were tested. Both ATC7 and THP1 cells 151 
were serum-starved in serum-free medium supplemented with 0.1% BSA approximately 16-152 
24 hours before the start of each experiment. ATC7 and/or ATC7-THP1 cells were treated 153 
with: LPS (Lipopolysaccharides from Escherichia coli O111: B4; Sigma, UK), pro-154 
inflammatory cytokines (mouse IL-1β, IL-6 and TNFα, 10 nM/ml; Miltenyi Biotec GmbH, 155 
Bergisch Gladbach, Germany), dexamethasone (DEX, Dexam thasone 21-phosphate 156 












Fragment 1-39; Sigma) as described in detail for each experiment in the result section. At the 158 
end of each experiment, cells were washed with ice-cold phosphate-buffered saline (PBS), 159 
and then sodium dodecyl sulfate (SDS)-lysis buffer (2% SDS, 50mM Tris pH 6.8, 10% 160 
glycerol) was added to each well. Cells were scraped off, and the lysate was collected in two 161 
aliquots and stored at -20C until processing for RNA and protein extraction as described in 162 
Figure 1.  163 
 164 
Quantitative RT-PCR  165 
 166 
For RNA quantification cells were lysed in RNA lysis buffer, and total RNA was 167 
purified using Ambion Pure-Link kit (Invitrogen, ThermoFisher Scientific). The cDNA 168 
template was reverse-transcribed from 1000ng of total RNA using Cloned AMV First-Strand 169 
cDNA synthesis kit (Invitrogen, ThermoFisher Scientfic). RTqPCR was performed as 170 
previously described (Park et al., 2013) using Power SYBR green PCR mix (Applied 171 
Biosystems, ThermoFisher Scientific) and 4 ng cDNA template. RTqPCR primers (listed in 172 
Supplementary Table 1) were used at a final concentration of 200nM and designed to span an 173 
exonic-exonic region to detect mature transcript (mRNA). Each sample was analised in 174 
duplicate and GAPDH was used as a house-keeping gene.175 
 176 
Western immunoblotting  177 
 178 
For protein quantification cells were lysed in SDS lysis buffer (2% SDS; 50 mM Tris 179 
pH 6.8; 10% glycerol) and Western immunoblotting performed as described in (Hazell t al. 180 
2019). In brief, all membranes were blocked with 1%BSA in Tris-buffered saline/0.05% 181 












Santa Cruz Biotechnology, USA), pCREB (1:1,000; Cell Signalling Technology, Inc., USA), 183 
followed by horseradish peroxidase-conjugated donkey α-rabbit secondary antibody (1:5,000; 184 
Santa Cruz Biotechnology). Vinculin (Goat α-vinculin primary (1:5,000) followed by a 185 
Donkey α-Goat secondary (1:5,000) (both Santa Cruz Biotechnology) was used as a loading 186 
control as previously shown (Hazell et al. 2019). Protein bands were visualized with 187 
Luminata Forte Western HRP substrate (Millipore Corporation, Billerica, MA, USA) using a 188 
G BOX (Syngene, Cambridge, UK) and densitometry was determined using Image J 189 




Graph Pad Prism version 7.00 (Graph Pad Software, La Jolla, CA, USA) and SPSS 194 
version 24 (IBM Corp., Armonk, NY, USA) was used for data graphing and statistical 195 
analysis, respectively. All data are expressed as mean ± SEM. For all experiments, one-way, 196 
two-way or three-way analysis of variance (ANOVA) was used. When a significant effect of 197 
main factors or interactions was found, a Tukey’s multiple comparison test (post one-way and 198 
two-way ANOVA) or Fisher’s LSD post hoc test (post three-way ANOVA) was used. 199 




LPS stimulation of ATC7 cells co-cultured with THP1 cells induces the expression of 204 













Our preliminary experiments demonstrated no significant changes in the expression of 207 
IL-6 mRNA in ATC7 cells in response to LPS stimulation, either alone (Supplementary 208 
Figure 1) or in co-treatment with Interferon-gamma (Supplementary Figure 2). Because 209 
resident macrophages are found in basal unstimulated conditions in the adrenal cortex in vivo 210 
(Boonen et al. 2015), we hypothesized that ATC7 cells would require the presence of 211 
activated immune cells for LPS to be able to affect the expression of pro-inflammatory 212 
cytokines and steroidogenic genes. Therefore, in this experiment we tested the effect of co-213 
culturing ATC7 cells with of THP1 derived macrophages (referred to as THP1) cells at 214 
various ratios, as well as the effect of treatment with various doses of LPS for 24 hours 215 
(Figure 2). Two-way ANOVA showed a significant effect of LPS (P<0.0003) but no effect of 216 
THP1 co-culture, nor interaction, was observed on IL-6 mRNA (Figure 2A). Although higher 217 
levels of IL-6 mRNA could be observed in co-cultured ATC7 cells co-cultured with THP1 218 
cells treated with LPS, post hoc test did not detect any specific difference between 219 
experimental groups. Next, we evaluated the dose-reponse effect of 24-hour LPS stimulation 220 
on ATC7 cells co-cultured with THP1 cells (co-cultured at a 1 ATC7: 2 THP1 cells ratio. 221 
One-way ANOVA revealed a significant effect of LPS on IL-6 mRNA expression (P=0.0032; 222 
Figure 2B), with a significant increase observed in cells treated with LPS at the dose of 1.25 223 
µg /ml and 5 µg /ml concentration (P=0.0453 and P=0.0024, respectively). In summary, we 224 
demonstrate the co-culture of ATC7 cells with THP1 cells increases the IL-6 mRNA 225 
expression. This increase is significantly potentiated by LPS stimulation in a dose-dependent 226 
manner.  227 
 228 
Effect of increasing ratio of THP1 co-culture and LPS stimulation on steroidogenic gene 229 













Significant effects of ACT7-THP1 cells co-culture and LPS treatment were also found 232 
on the expression of key steroidogenic genes (Figure 3). Specifically, there was an overall 233 
effect of LPS on StAR mRNA (P=0.021; Figure 3A) and an overall effect of THP1 co-culture 234 
on MC2R mRNA levels (P=0.001; Figure 3B). As observed for IL-6 mRNA, post hoc 235 
analysis did not reveal any significant differences b tween groups; however, StAR mRNA 236 
levels appeared reduced in LPS-treated ATC7 cells co-cultured with THP1 cells, compared to 237 
untreated ATC7 cells co-cultured with THP1 cells, and MC2R mRNA levels were elevated in 238 
ACT7-THP1 cells with low THP1 ratio (0.25 and 0.5), compared to single ATC7 cells. No 239 
effects of co-culture, or of LPS, were found on MRAP mRNA (Figure 3C) or SF-1 mRNA 240 
(Figure 3D). However, a significant effect of THP1 (P<0.0001), as well as a significant effect 241 
of THP1xLPS interaction (P=0.048), was found on DAX-1 mRNA (Figure 3E). The post hoc 242 
test revealed a significant decrease of DAX-1 mRNA in ATC7 cells co-cultured with THP1  243 
cells treated with either LPS or vehicle. Interestingly, in ATC7 only cells, there was a trend 244 
of increase in the expression of DAX-1 mRNA in response to LPS stimulation (P=0.072) 245 
compared to ATC7 cells treated with vehicle. In summary, in this experiment, we 246 
demonstrate that LPS stimulation of  ATC7 cells co-cultured with THP1 cells modulates the 247 
steroidogenic pathway mainly by reducing both StAR m NA expression and DAX-1 mRNA 248 
expression.  249 
 250 
Dose-dependent effects of LPS on the expression of steroidogenic genes in ATC7 cells co-251 
cultured with THP1 cells. 252 
 253 
In this experiment, we evaluated the dose-response effect of 24-hour LPS stimulation 254 
on the expression of steroidogenic genes in ATC7 cells o-cultured with THP1 cells at a 1:2 255 












mRNA (P<0.0001; Figure 4A) and DAX-1 mRNA (P<0.0001; Figure 4E). Compared to 257 
controls, StAR mRNA expression was significantly decreased in cells treated with LPS at 258 
doses between 0.05 and 5µg/mL, (p<0.0001; Figure 4A), whereas a significant decrease in 259 
DAX-1 was observed in cells treated with LPS at doses between 0.5 and 5µg/mL (Figure 4E). 260 
Consistent with the previous experiment, there was no effect of LPS on MC2R, MRAP and 261 
SF-1 mRNA (Figure 3B-D). In accordance with the mRNA data, analysis of StAR protein 262 
showed a significant effect of LPS (P<0.0001; Figure 4F), with a significant decrease in cells 263 
treated with LPS doses between 0.75 and 5µg/mL. In summary, data from this experiment 264 
demonstrate that the LPS induced suppression of StAR mRNA expression and protein 265 
translation and DAX-1 mRNA expression occurs in a dose-dependent manner  266 
 267 
Time-course effect of cytokines on IL-6 and steroidogenic genes mRNA levels in ATC7 268 
only cells and in ATC7 cells co-cultured with THP1 cells. 269 
 270 
Treatment of THP1 cells with LPS results in the secretion of pro-inflammatory 271 
cytokines, including IL-1β, IL-6 and TNFα (Wehrhahn et al. 2010; Palacio et al. 2011; 272 
Schildberger et al. 2013a). Therefore, to investigate whether the effects of LPS on IL-6 273 
mRNA and on steroidogenic gene mRNA may be mediated by specific macrophage’s 274 
cytokines, in this experiment we tested the time-course of the effects of IL-1β, IL-6 and 275 
TNFα treatment in ATC7 only cells and in ATC7 cells co-cultured with THP1 cells (Figure 276 
5). 277 
 278 
The effect of cytokines on IL-6 mRNA is shown in Figure 5A. In ATC7 only cells, 279 
we found a significant effect of IL-1β treatment (P=0.003), time (P=0.030) and interaction 280 












untreated 1h); we also found a significant effect of IL-6 treatment (P=0.012), time 282 
(P=0.0001) and interaction (P=0.014), with a significant increase in IL-6 mRNA at 1h 283 
(P=0.001 vs time 0; P=0.004 vs untreated 1h, see insert in Figure 5A), and a significa t effect 284 
of TNFα treatment, time and interaction (all P<0.0001) with an increase in IL-6 mRNA at 1h 285 
(P<0.0001 vs time 0 and vs untreated 1h) and at 3h (P=0.027 vs time 0;  P=0.016 vs untreated 286 
3h). In ATC7-THP1 cells,  we found a significant effect of IL-1β treatment (P=0.0001), time 287 
(P=0.035) and interaction (P=0.020), with a significant increase in IL-6 mRNA at 12h 288 
(P=0.010 vs time 0; P=0.007 vs untreated 12h), but only a trend of increase at 6h (P=0.072 vs 289 
time 0; P=0.052 vs untreated 6h). We also found a significant effect of IL-6 treatment 290 
(P=0.006) and time (P=0.045),  with a trend at 12h (P=0.096 vs untreated at 12h), and an 291 
effect of TNFα treatment in cells treated with (P=0.001), but no significant changes in the 292 
post hoc test. 293 
 294 
The effect of cytokines on StAR mRNA is shown in Figure 5B. In ATC7 only cells, 295 
we found no effect of IL-1β, IL-6 or TNFα treatment nor effect of time in cells treated with 296 
IL-1β or IL-6, but a significant effect of time in cells treated with TNFα (P=0.014), with no 297 
significant changes found in the post hoc analysis. In ATC7-THP1 cells, we found no effect 298 
of IL-1β treatment or time, whereas there was an effect of IL-6 treatment (P=0.002) but no 299 
significant changes in the post hoc analysis. We also found an effect of TNFα treatment 300 
(P=0.0003), but only a trend of the effect of time (P=0.0541) and interactions (P=0.081); post 301 
hoc test revealed a significant decrease in StAR at 1h (P=0.043 vs time 0; P=0.023 vs 302 
untreated 1h). 303 
 304 
The effect of cytokines on MC2R mRNA  is shown in Fgure 5C. In ATC7 only cells, 305 












treatment (P<0.0001), time (P=0.0006) and interaction (P=0.008), with a significant increase 307 
in MC2R mRNA at 3h (P=0.002 vs time 0; P= 0.008 vs untreated 3h) and at 6h (P=0.001 vs 308 
time 0; P=0.001 vs untreated 6h). We also found a significant effect of ime in cells treated 309 
with TNFα (P=0.011), but no significant changes in the post hoc analysis. In ATC7-THP1 310 
cells, we found an effect of time in cells treated with IL-1β (P<0.0001), IL-6 (P=0.0003) or 311 
TNFα (P=0.002), and a trend of the effect of IL-6 treatment (P=0.0562), with a decrease in 312 
MC2R mRNA at 6h in both untreated cells (P=0.007 vs time 0) and cells treated with IL-313 
1β (P=0.008  vs time 0). 314 
 315 
The effect of cytokines on MRAP mRNA is shown in Figure 5D. In ATC7 only cells, 316 
we found no effect of treatment or time in cells treated with IL-1β or TNFα, but a significant 317 
effect of IL-6 treatment (P=0.04), with no significant changes in the post hoc analysis. In 318 
ATC7-THP1 cells, we found no effect of IL-1β treatment or time, but a significant effect of 319 
IL-6 treatment (P=0.005), with a significant increas  in MRAP mRNA at 6h (P=0.04 vs 320 
untreated 6h). We also found a significant effect of TNFα treatment (P=0.003) and time 321 
(P=0.012), with a significant decrease in MRAP mRNA at 3h (P=0.011 vs time 0; P=0.087 vs 322 
untreated 6h). 323 
 324 
The effect of cytokines on SF-1 mRNA is shown in Figure 5E.  In ATC7 only cells, 325 
we found no effect of treatment or time in cells treated with IL-1β, IL-6 or TNFα. In contrast, 326 
in ATC7-THP1 cells, we found a significant effect of IL-1β treatment (P=0.024) and  327 
TNFα treatment (P=0.042), but only a trend of the effect of IL-6 treatment (P=0.055), with 328 













The effect of cytokines on DAX-1 mRNA is shown in Figure 5F. In ATC7 only cells, 331 
we found no effect of IL-1β treatment or time, whereas we found a significant effect of time 332 
in cells treated with IL-6, with no significant changes in the post hoc analysis, and a 333 
significant effect of TNFα treatment (P=0.011) and interaction (P=0.045), and  trend of 334 
effect in time (P=0.076), with a decrease in DAX-1 mRNA at 12h (P=0.048). In ATC7-THP1 335 
cells, we found no effect of treatment or time in cells treated with IL-1β or IL-6, and only a 336 
trend of the effect of TNFα  (P=0.054). In summary, cytokines treatment can affect the levels 337 
of IL-6 and steroidogenic genes expression, and these effects are different in ATC7 cells co-338 
cultured with THP1 and ATC7 alone.  339 
 340 
Effects of Dexamethasone and LPS co-treatment on IL-6 and steroidogenic gene mRNA 341 
levels in ATC7 cells co-cultured with THP1 cells. 342 
 343 
In the following sets of experiments, we tested the hypothesis that the effects of LPS 344 
on IL-6 and steroidogenic gene expression can be modulated by treatment with the synthetic 345 
glucocorticoid dexamethasone (DEX). Firstly, we investigated the effect of 24-hour co-346 
treatment with DEX and LPS on the expression of IL-6 mRNA and steroidogenic genes 347 
mRNA in ATC7 cells co-cultured with THP1 cells (Figure 6). We found a significant overall 348 
effect of LPS (P<0.0001) on IL-6 mRNA, but no significant effect of DEX nor interaction 349 
(Figure 6A). Post hoc test revealed a significant increase in IL-6 mRNA in control cells 350 
treated with 5 µg/mL LPS (P=0.0009) and in cells co-treated with 5 µg/mL LPS and 100µM 351 
DEX (P=0.0037), compared to untreated control and 100µM DEX-treated ATC7-THP1 cells, 352 
respectively; the effect of  5 µg/mL LPS was not observed in ATC7-THP1 cells co-treated 353 
with 1µM and 10µM DEX. We did not observe any effect of the lower dose of LPS 354 













Analysis of the effects of DEX and LPS on steroidogenic gene expression revealed a 357 
significant effect of DEX (P<0.0001) and a significant DEX x LPS interaction (P=0.0009) on 358 
StAR mRNA (Figure 6B). StAR mRNA levels were decreas d in cells treated with 5µg/mL 359 
LPS (P=0.0037), compared to control ATC7-THP1 cells, and these effects were prevented by 360 
1 µM DEX, but not by 10 and 100µM DEX. We also observed a significant decrease in StAR 361 
mRNA in cells treated with both 1µM DEX and 0.05µg/mL LPS (P=0.0116) compared to 362 
control ATC7-THP1 cells, suggesting a synergistic effect of DEX and LPS at low doses. 363 
There was also a significant effect of DEX (P=0.0048) and DEX x LPS interaction 364 
(P=0.0051) on DAX-1 mRNA (Figure 6F). However, post hoc analysis did not reveal any 365 
significant effect of LPS or DEX alone, but a trend of decrease in DAX-1 mRNA levels was 366 
found in cells treated with 1µM DEX and 0.05µg/mL LPS and in cells treated with 100µM 367 
DEX and 5µg/mL LPS (P=0.0887 and P=0.0800, respectively, compared to control ATC7-368 
THP1 cells). Co-treatment with DEX and LPS did not affect MC2R, MRAP or SF-1 mRNA 369 
levels (Figure 6 C-E). In this experiment, we show that glucocorticoid co-administration can 370 
prevent the LPS induced IL-6 mRNA expression and steroidogenic gene changes  (StAR 371 
mRNA and DAX-1 mRNA expression) in ATC7-THP1 cells in a dose-dependent manner  372 
 373 
Effects of Dexamethasone pre-treatment on LPS-induced changes in IL-6 and 374 
steroidogenic gene mRNA levels in ATC7 cells co-cultured with THP1 cells. 375 
 376 
Our previous experiment has shown that ATC7 cells co-cultured with THP1 cells 377 
treated with DEX prevent some of the effects of LPS on IL-6, StAR and DAX-1 mRNA, but 378 
only at the lower doses of 1µM and 10µM. In this experiment, we aimed to test whether pre-379 












ATC7 cells co-cultured with THP1 cells. Twenty-four hours treatment with DEX was 381 
followed by 24-h treatment with LPS (at the dose of 0.05 of 5 µg/mL) alone or in 382 
combination with DEX (Figure 7). Three-way ANOVA revealed a significant effect of LPS 383 
on IL-6 mRNA (P<0.00001) but no effect of DEX pre-tatment, DEX co-treatment, nor 384 
interactions (Figure 7A). IL-6 mRNA levels were significantly higher in cells treated with 385 
5nM LPS, and this effect was prevented in cells pre-treated with DEX, but not in cells both 386 
pre- and co-treated with DEX. Three-way ANOVA also revealed a significant effect of LPS 387 
on StAR (P<0.0001; Figure 7B) and DAX-1 mRNA (P<0.0001; Figure 7F), but no effect of 388 
DEX pre-treatment, DEX co-treatment, nor interactions on either gene. LPS treatment 389 
decreased StAR mRNA levels and neither pre- nor co-treatment with DEX prevented these 390 
effects. Similarly, LPS treatment decreased DAX-1 mRNA levels, but this effect was 391 
prevented in cells treated with 0.05µg/mL LPS pre- and co-treated with DEX. We also 392 
observed an overall effect of LPS on MC2R mRNA (P=0.0180; Figure 7C); however, a 393 
significant decrease in MC2R mRNA was only observed in cells treated with 5µg/mL LPS 394 
and pre-treated with DEX. Finally, a significant effect of DEX co-treatment was observed on 395 
MRAP mRNA (Figure 7D), however, post hoc analysis dd not reveal any significant 396 
difference between specific treatment groups. We conclude that in the in ATC7-THP1 cells, 397 
there is no effect of dexamethasone pre-treatment on LPS induced IL-6 mRNA expression 398 
and steroidogenic gene activation with our without subsequent glucocorticoid 399 
coadministration. 400 
 401 
Effect of LPS on ACTH- induced IL-6 mRNA and steroidogenic gene expression in ATC7 402 













Studies in humans and in rodents have shown that LPS-induced glucocorticoid secretion can 405 
occur through its effects on the HPA axis (Chrousos 1995). In addition to regulating the 406 
secretion of CRH in the hypothalamus, and of ACTH in the pituitary, LPS administration directly 407 
activates the adrenal gland steroidogenic pathway and c n potentiate the effects of ACTH on 408 
glucocorticoid synthesis (Kanczkowski et al. 2016). Therefore, we decided to investigate the 409 
effects of LPS treatment on Il-6 and steroidogenic genes mRNA in both ATC7 alone and 410 
ATC7 cells co-cultured with THP1 cells (Figure 8). In these experiments set, ATC7 only 411 
cells and ATC7-THP1 cells were treated with LPS 5µg/mL for 24 hours and then treated with 412 
ACTH 10 nM for up to 2h. Three-way ANOVA analysis of IL-6 mRNA data showed a 413 
significant effect of ACTH (P<0.0001), LPS (P<0.0001), THP1 (P=0.02) as well as ACTH x 414 
THP1 (P=0.007), LPS x THP1 (P<0.0001) and ACTH x LPS ( =0.01) interactions (Figure 415 
8A). To our surprise, we found that ACTH alone increased IL-6 mRNA levels in ATC7 cells, 416 
and this effect was potentiated by pre-treatment with LPS. Interestingly, ACTH alone did not 417 
increase IL-6 mRNA in ATC7-THP1 cells, whereas a signif cant increase was observed when 418 
ATC7-THP1 cells were treated with LPS. 419 
 420 
Analysis of StAR mRNA revealed a significant effect of ACTH (P<0.0001), LPS 421 
(P=0.001) and THP1 (P<0.0001) as well as a significant ACTH x THP1 interaction 422 
(P=0.005) (Figure 8B). As expected, StAR mRNA levels were increased in ATC7 only cells 423 
treated with ACTH, and LPS did not affect such effect. However, the increase in StAR 424 
mRNA induced by ACTH was reduced in ATC7-THP1 cells, an effect that was further 425 
potentiated by LPS. A significant effect of ACTH (P<0.0001) and THP1 (P=0.02), as well as 426 
THP1 x LPS interaction (P=0.05) was also observed on MC2R mRNA levels (Figure 8C). 427 
However, while there were no significant changes in ATC7 cells treated with ACTH, even 428 












treated with ACTH only, when compared to ATC7 only cells. DAX-1 mRNA levels were 430 
also affected by both ACTH (P=0.03) and THP1 (P<0.00 1), with a significant effect of 431 
ACTH x THP1 interaction (P=0.02), whereas only a trend of the effect of LPS was observed 432 
(P=0.08) (Figure 8F). DAX-1 mRNA levels were decreas d in ATC7 cells treated with 433 
ACTH±LPS at 2h, compared to time 0, whereas a significant decrease was observed in 434 
ACT7-THP1 cells prior to ACTH treatment, and no further decrease was observed after 435 
ACTH treatment, nor LPS treatment had any further effect. To our surprise, only a trend of 436 
effect of ACTH was observed on MRAP (figure 8D), while a significant effect of THP1 437 
(P<0.0001), and a trend of effect of LPS (P=0.09), was found on SF-1 mRNA levels, with a 438 
significant overall decrease in ATC7-THP1 cells trea ed with LPS (Figure 8E). In these 439 
experiments, we demonstrate that the LPS and ACTH induced adrenal IL-6 mRNA 440 
expression and steroidogenic genes activation are significantly modulated by the THP1 cells.  441 
 442 
To evaluate whether the decrease in ACTH-induced StAR mRNA in ATC7 cells co-443 
cultured with THP1 cells was associated with a decreased activation of CREB, we measured 444 
the levels of pCREB using Western immunoblot (Figure 8G). Although there was no 445 
significant effect of ACTH, LPS or THP1, a significant ACTH x LPS interaction was 446 
detected (P=0.02). Post hoc analysis revealed that w ile ACTH increased pCREB levels in 447 
ATC7 only cells pre-treated with vehicle (P=0.02), only a trend of effect was found in ATC7 448 
only cells pre-treated with LPS (P=0.07), and no significant effect of ACTH was found in 449 




 Recent data have provided evidences of HPA axis-independent, intra-adrenal 454 












stress (Boonen et al. 2015). It is likely that such mechanisms could complement or augment 456 
the well-known HPA axis activation during critical illness. The adrenal tissue 457 
microenvironment contains a variety of cells, including neural cells, adipocytes, endothelial 458 
and immune cells, that could indeed regulate adrenal steroidogenesis (Boonen et al. 2015). 459 
The interaction of steroidogenic cells with immune cells is of particular importance because 460 
several studies have shown that the generalized inflammation that accompanies acute stress is 461 
associated with an infiltration of the adrenal cortex by immune cells (Kanczkowski et al. 462 
2013a; Jennewein et al. 2016). This immune-steroidogenic cross-talk could occur either 463 
through the activation of residence macrophages and/or by the recruitment of circulating 464 
immune cells into the adrenal cortex. One study suggested that systemic immune cells, rather 465 
than the adrenal cells, are the major regulator of the TLR-mediated adrenal activation 466 
(Kanczkowski et al. 2013b). It is undoubtedly the case that the adrenals gl nds, like the 467 
thyroid gland, have the highest blood supply er gram of tissue in the body, and it is likely 468 
that the adrenal tissue will be flooded by immune-eff ctor cells during acute inflammatory 469 
stress.  470 
 471 
The current study reports the characterization of a novel co-culture model to 472 
investigate these interactions. The use of the adrenocortical tumour ATC7 cell line with 473 
complete zona fasciculata cell phenotype enabled us to assess the effect of an inflammatory 474 
stimulus on the expression of the pro-inflammatory cytokine IL-6 mRNA and the expression 475 
of key steroidogenic genes. Rat and human adrenal cells do express a variety of pro-476 
inflammatory cytokines in response to immune activation, including TNFα, IL-1, IL-6, IL-18, 477 
TGFβ (Judd 1997; Bornstein et al. 2004a). We have chosen to measure the expression of IL-6 478 
because it can be induced by inflammation directly as well as in response to IL-1β. 479 












directly or via activation of the CRH-ACTH axis (Bethin et al. 2000; Bornstein et al. 2004a; 481 
Chrousos et al. 2015). In humans, the presence of IL-6, IL-6 receptor and IL-6 mRNA in the 482 
adrenal cortex suggests that IL6 could play a paracrine or autocrine role in the immune, 483 
adrenal cross-talk (Päth et al. 1997; Gonzalez-hernandez & Scherbaum 2016). We decided to 484 
use the THP1 cell line because this is a commonly used model to study 485 
monocyte/macrophage functions (Tsuchiya et al. 1980). THP1 cells have been used before in 486 
other co-culture models including vascular smooth muscle cells (Li et al. 2006; Zhang et al. 487 
2008), adipocytes (Spencer t al. 2010) , T-lymphocytes (Azenabor et al. 2011), platelets 488 
(Aslam et al. 2007) and intestinal cells (Watanabe et al. 2004). Furthermore, THP1 cells, and 489 
particularly the matured macrophages, are known to secrete several pro-inflammatory 490 
cytokines as a result of LPS stimulation including TNFα, IL-1β, IL-6, IL-8 and IL-10 491 
(Wehrhahn et al. 2010; Palacio et al. 2011; Schildberger et al. 2013b).  492 
 493 
In the present study, we show a significant increase in IL-6 mRNA expression in 494 
ATC7 cells in response to LPS only when these cells are co-cultured with the THP1 cells, 495 
suggesting that the expression of adrenal pro-inflamm tory cytokines in response to 496 
inflammatory stress is dependent on the presence of immune cells. Because LPS had no 497 
effect on ATC7 cells alone, we hypothesize that, in our co-culture experimental model, LPS 498 
induces the secretion of cytokines by THP1 macrophages which then acts on the adrenal cells 499 
resulting in the expression of IL-6 mRNA. We have also found that the effects of LPS on IL-500 
6 mRNA is dependent on the ATC7 to THP-1 cell ratio. This suggests that in vivo, the 501 
increased expression of adrenal pro-inflammatory cytokines during acute stress could occur 502 
by increased recruitment of immune cells into the adrenal cortex. As discussed above, THP1 503 
cells secrete a number of pro-inflammatory cytokines in response to LPS stimulation, 504 












Schildberger et al. 2013b). Wehrhahn et al. investigated the function of the transient receptor 506 
potential melastatin 2 (TRPM2) in the LPS induced cytokine production by the THP1 cells at 507 
1h, 4h and 16 hours. They were able to measure significant increases in TNFα, IL-6, IL-8 and 508 
IL-10 (Wehrhahn et al. 2010). Palacio et al. investigated the anti-inflammatory effect of N-509 
acetylcysteine (NAC) on LPS activated THP1 macrophages under mild oxidative conditions. 510 
The cytokine mRNA and protein for IL-1 β, TNFα, IL-6, IL-8 and IL-10 were measured in 511 
the cell culture supernatants at 2, 4, 6 and 24 hours. In the absence of NAC, the TNFα mRNA 512 
peaked at 2 hours from LPS stimulation and gradually decreased up to 24 hours compared to 513 
the untreated cells. The IL-1β mRNA was elevated between 2-6 hours then decreased at the 514 
24-hour time point, and the IL-6 mRNA peaked between 4 and 6 hours (Palacio et al. 2011). 515 
Schildberger et al. measured the cytokine concentrations in the cell media (TNFα, IL-6, IL-8 516 
and IL-10) after LPS stimulation of THP1 cell in comparison to the cytokine release pattern 517 
of isolated human peripheral blood mononuclear cells (PBMC) and monocytes (Schildberger 518 
et al. 2013a). In Schildberger et al. study, TNFα peaked at 4 hours, while the IL-1β 519 
concentrations peaked at 6 hours and remained elevat d up to 24 hours. They also found the 520 
THP1 cells did not secrete any IL-6 and IL-10 in the media after LPS stimulation and 521 
secreted far less IL-8 compared to human peripheral blood mononuclear cells (PBMC) and 522 
monocytes. However, the THP1 had comparable TNFα secretion to human peripheral blood 523 
mononuclear cells (PBMC) and monocytes. In light of hese studies, we investigated the time 524 
course of the effects of IL-1β, IL-6 and TNFα on IL-6 and steroidogenic gene expression in 525 
ATC7 cells alone and in ATC7 cells co-cultured with THP1 cells. Our results show that 526 
treatment with cytokines can affect IL-6 mRNA, a result that is consistent with previous 527 
studies (Judd & MacLeod 1992), and steroidogenic gene expression, and that these effects are 528 
different in ATC7-THP1 and ATC7 alone. Interestingly, we found differences in the 529 











cells alone, and, surprisingly, IL-6 induced a small but significant increase in IL-6 mRNA 531 
expression in ATC7 cells cultured alone, but not in co-cultured cells, suggesting that co-532 
incubation with THP1 has protective effect on pro-inflammatory response to IL-6 in the 533 
adrenal. Changes in steroidogenic gene expression were also observed in response to 534 
cytokines in both ATC7 and ATC7-THP1 cells, including a decrease in StAR mRNA in 535 
response to TNFa, which is consistent with the effects observed in ATC7-THP1 cells treated 536 
with LPSWe also observed changes in MRAP mRNA, with both a decrease and an increase 537 
following IL-1β and IL-6 treatments, respectivelly, and a decrease in DAX-1 mRNA 538 
following IL-1β treatment, although such effect only reached stistical significance in the post 539 
hot test in co-cultured cells (MRAP mRNA) or in ATC7 cells alone (DAX-1 mRNA).  These 540 
changes in DAX-1 are also constent wih the effects of LPS treatment in ATC7-THP1 cells. 541 
The data are important as they provide an insight of he role of specific cytokines in 542 
regulating immune and steroidigenic response in adrenal glands exposed to inflammatory 543 
stimulus. 544 
 545 
We have also assessed the effect of glucocorticoids on immune-adrenal interactions. 546 
This approach is novel since, to our knowledge, the eff cts of glucocorticoids on the HPA 547 
axis responses to inflammation has only been investigated at a system level, and not directly 548 
in the adrenal gland cells. We found a significant effect of a high dose of LPS on the increase 549 
of IL-6 mRNA expression. This increase was suppressed by low and medium doses of DEX. 550 
A similar dose-dependent suppression was noted in the S AR mRNA expression as a result of 551 
LPS stimulation. Furthermore, we found a significant effect of DEX on the DAX-1 mRNA 552 
response to LPS stimulation, whereas we noted a trend in a decrease of DAX-1 mRNA 553 
expression dependent on LPS and DEX dose co-stimulation. Gummow et al. investigated the 554 












adrenocortical cells, and they found an increase in DAX-1 mRNA expression and a decrease 556 
in StAR mRNA expression that was mediated by glucocorticoid receptor activation 557 
(Gummow et al. 2006). In our experiments, we did not find any effect of dexamethasone co-558 
incubation on steroidogenic gene expression in ATCH-THP1 cells in the absence of LPS co-559 
stimulation. Nevertheless, our data further support a direct effect of glucocorticoids on the 560 
steroidogenic network activity as shown in previous work from our group (Spiga et al. 2020). 561 
This suggests that during acute inflammatory stress, ystemic administration of 562 
glucocorticoids can directly modulate steroidogenesis in an HPA axis-independent manner. 563 
 564 
Furthermore, we investigated the temporal relation between the glucocorticoid 565 
response and LPS stimulation in regulating the expression of IL-6 and steroidogenic genes. 566 
Despite traditional views according to which glucocorticoids are considered uniformly anti-567 
inflammatory, research in the last decade has suggeted that glucocorticoids can have a 568 
bimodal action: both pro-inflammatory and anti-inflammatory (Sapolsky et al. 2000; Sorrells 569 
et al. 2009). This bimodal effect seems to depend on the time of glucocorticoid 570 
administration in relation to the inflammatory stres stimulus. A pro-inflammatory effect of 571 
glucocorticoids has been demonstrated in immune-competent cell lines (macrophages) 572 
(Smyth et al. 2004) and in the central nervous system (hippocampal icroglia) (Frank et al. 573 
2007). We investigated whether this effect occurs within the isolated adrenal cells depending 574 
on the time of glucocorticoid administration in relation to the inflammatory stress (LPS 575 
stimulation). We found that DEX pre-treatment prevented the LPS-induced IL-6 mRNA 576 
response when compared to co-treated cells, suggestin  that the so-called bimodal effect of 577 
steroids (anti- and pro-inflammatory) on IL-6 regulation that has been described in immune 578 
and neural cell lines does not apply to adrenal cells, at least within the experimental 579 













Because ACTH plasma levels increase in response to inflammatory stress, we also 582 
investigated the effects of ACTH treatment on IL-6 mRNA and steroidogenic genes mRNA 583 
in both ATC7 alone and in ATC7 cells co-cultured with THP1 cells. To our surprise, we 584 
found that ACTH alone was able to induce IL-6 mRNA in ATC7 cells, and this effect was 585 
potentiated by pre-treatment with LPS. Interestingly, the effect of ACTH on IL-6 mRNA was 586 
not observed in ATC7 cells co-cultured with THP1 cells in the absence of LPS, suggesting 587 
that anti-inflammatory cytokines secreted by THP1 cells in basal conditions may protect the 588 
adrenal cells from a non-inflammatory immune activation mediated by ACTH. We have 589 
recently shown that ACTH treatment dynamically increases the expression of steroidogenic 590 
genes in ATC7 cells (Hazell et al. 2019). Our present data confirmed our previous findings, 591 
but also show that the dynamic effect of ACTH is dirupted in ATC7 cells co-cultured with 592 
THP1 cells, with a smaller effect on StAR mRNA, which was further decreased by pre-593 
treatment with LPS, and complete suppression of DAX-1 mRNA. These effects were 594 
associated with a decrease in pCREB levels, suggestin  that the effects of co-culture with 595 
THP1 cells may occur at the levels of cAMP/PKA signalli g. Interestingly, the effects of 596 
ACTH on other steroidogenic genes, including MC2R, MRAP and SF-1 were not affected by 597 
co-culture with THP1 cells, nor by pre-treatment wih LPS. The effect of ACTH on IL-6 598 
mRNA and steroidogenic genes was significantly different in the presence of THP1 cells. IL-599 
6 mRNA and phosphorylation of CREB appeared enhanced by ACTH in the presence to 600 
THP1 cells and LPS, while the suppression of STAR mNA and DAX-1 mRNA was more 601 
pronounced in the LPS-treated cells, compared to vehicle-treated ATC-THP1 cells. A link 602 
between an increase in CREB phosphorylation and progesterone levels in response to IL-1b 603 
has been shown in granulosa cells (Dang et al. 2017). Therefore, it is tempting to speculate 604 












mechanism. Overall our results suggest that immune-adr nal cross-talk may be integrated 606 
with the hormonal response of the HPA axis during acute stress.  607 
 608 
In conclusion, we report a novel co-culture model suitable for assessing immune-609 
adrenal interactions in the context of stress. We demonstrated that the expression of pro-610 
inflammatory adrenal cytokines after LPS stimulation is dependent on the ratio of adrenal and 611 
immune cells. We have also noted that the presence of THP1 cells can modulate the response 612 
of the steroidogenic gene network to LPS activation, and this is further modulated by ACTH 613 
stimulation. Further work is needed to understand the cytokine interaction that occurs 614 
between the immune and adrenal cells and its correlation to the steroidogenic gene activation 615 
during stress.  616 
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Figure legends 809 
 810 
Figure 1. Diagram of methods used to co-culture ATC7 and THP1 cells. The ATC7 cells 811 
and the THP1 cells are first cultured separately (1). Then cells are co-incubated using a 812 
transwell system and undergo various treatments with LPS, DEX or cytokines (2). At the end 813 
of treatment, the well containing the THP1 cells is removed and cells are discarded. ATC7 814 
cells are collected and processed for mRNA and protein extraction and measurement by RT-815 
qPCR and western immunoblotting, respectively (3). 816 
 817 
Figure 2. Effect of LPS treatment in ATC7 cells co-cultured with THP1 cells on IL-6 818 
mRNA expression in ATC7 cells. ATC7 cells were cultured alone (A) or co-cultured with 819 
THP1 cells (A and B) and treated with LPS for 24-h. Relative levels of IL-6 mRNA were 820 
measured in ATC7 cells by RTqPCR and GAPDH was used as a house-keeping gene. (A) 821 
Effect of increasing ATC7:THP1 cells ratio and LPS treatment (5μg/mL) on IL-6 mRNA 822 
expression in ATC7 cells. Data are the mean ± SEM (n=4/group) and are expressed as fold 823 
induction of untreated ATC7 (1: 0) cells. Data were analyzed by two-way ANOVA, followed 824 
by Tukey’s multiple comparison test. (B) Effect of increasing doses of LPS in ATC7 cells co-825 
cultured with THP1 cells (1:2 ratio) on IL-6 mRNA expression in ATC7 cells. Data are the 826 
mean ± SEM (n=4/group) and are expressed as fold induction of untreated ATC7 cells co-827 
cultured with THP1 cells (Ctrl). Data were analyzed by one-way ANOVA, followed by 828 













Figure 3. Effect of increasing THP1 cells ratio and LPS stimulation on steroidogenic 831 
gene expression in ATC7 cells. ACT7 cells were cultured alone or co-cultured with THP1 832 
cells and treated with LPS (5μg/mL) for 24-h. The relative level of steroidogenic genes 833 
mRNA was measured in ATC7 cells by RTqPCR and GAPDH was used as a house-keeping 834 
gene. Data are the mean ± SEM (n=4/group) and are expressed as fold induction of untreated 835 
ATC7 cells (1:0); data were analyzed by two-way ANOVA followed by Tukey’s multiple 836 
comparison test. Effect of LPS: **P<0.01; ***P<0.001; ****P<0.0001 vs untreated ATC7 837 
(1:0) cells; ^^^^ P<0.0001 vs LPS-treated ATC7 (1:0) cells.  838 
 839 
Figure 4. Effect of LPS treatment in ATC7 cells co-cultured with THP1 cells on 840 
steroidogenic gene expression and StAR protein in ATC7 cells. ATC7 cells were co-841 
cultured with THP1 at 1:2 ratio and treated with LPS for 24-h. (A-E) Effect of increasing 842 
doses of LPS on steroidogenic genes mRNA expression. Relative levels of IL-6 and 843 
steroidogenic genes mRNA were measured in ATC7 cells by RTqPCR and GAPDH was 844 
used as a house-keeping gene. (F) Effect of increasing doses LPS on StAR protein in ATC7 845 
cells. Relative levels of StAR protein were measured in ATC7 cells by western 846 
immunoblotting, and data were normalized to vinculin. Data are the mean ±SEM (n=4/group) 847 
and are expressed as fold induction of untreated ATC7 cells co-cultured with THP1 cells 848 
(Ctrl); data were analyzed by one-way ANOVA followed by Tukey’s multiple comparison 849 
test. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001 vs Ctrl. 850 
 851 
Figure 5. Effect of cytokines treatment in ATC7 only cells and in ATC7 cells co-cultured 852 
with THP1 cells on IL-6 mRNA and steroidogenic genes mRNA expression in ATC7 853 
cells. ATC7 only cells and ATC7 cells co-cultured with THP1 cells were either left untreated 854 












h. Relative levels of IL-6 and steroidogenic genes mRNA were measured in ATC7 cells by 856 
RTqPCR and GAPDH was used as house-keeping gene. Data are the mean ±SEM 857 
(n=3/group). and are expressed as fold induction of untreated ATC7 only cells or ATC7 cells 858 
co-cultured with THP1 cells at time 0 (Ctrl); data were analyzed by two-way ANOVA 859 
followed by Tukey’s multiple comparison test. *P< 0.05; **P< 0.01 vs Ctrl; ^P<0.05; 860 
^^P<0.01 vs untreated cells at the same time point. 861 
 862 
Figure 6. Effect of dexamethasone and LPS treatment in ATC7 cells co-cultured with 863 
THP1 cells on IL-6 and steroidogenic genes mRNA expression ATC7 cells. ATC7 cells 864 
co-cultured with THP1 cells were treated with dexamethasone (DEX, 1, 10 and 100 µM) 865 
and/or LPS (0.05 and 5 µg/mL) for 24-h. Relative leve s of Il-6 and steroidogenic genes 866 
mRNA were measured in ATC7 cells by RTqPCR and GAPDH was used as a house-keeping 867 
gene. Data are the mean ±SEM (n=6/group) and are expressed as fold induction of untreated 868 
Ctrl cells; data were analyzed by two-way ANOVA followed by Tukey’s multiple 869 
comparison test. *P< 0.05; **P< 0.01; ***P< 0.001 vs untreated Ctrl; ^P<0.05 vs untreated 870 
cells of the same DEX treatment group.   871 
 872 
Figure 7. Effect dexamethasone pre-treatment, and dexamethasone and LPS co-873 
treatment in ATC7 cells co-cultured with THP1 cells on IL-6 and steroidogenic genes 874 
mRNA expression in ATC7 cells. ATC7 cells co-cultured with THP1 cells were pre-trea ed 875 
with dexamethasone (DEX, 100 µM) for 24-h, and then co-treated with LPS (0.05 or 5 876 
µg/mL) and/or dexamethasone (100 µM) for 24-h. Relative levels of IL-6 and steroidogenic 877 
genes mRNA were measured in ATC7 cells by RTqPCR and GAPDH was used as house-878 
keeping gene. Data are the mean ±SEM (n=6/group) and are expressed as fold induction of 879 












test. ***P< 0.001; ****P< 0.0001 vs LPS-untreated Ctrl; ^P<0.05; ^^P<0.01 ^^^P<0.001; 881 
^^^^P<0.0001 vs Ctrl cells of the same LPS±DEX treatment. The closed bars denote DEX 882 
pre-treated cells.  883 
 884 
Figure 8. Effect of LPS on ACTH-induced IL-6 mRNA and steroidogenic pathway 885 
activity. ATC7 cultured alone and ATC7 cells co-cultured with THP1 cells were incubated 886 
with LPS (5 µg/mL) and then treated with ACTH for up to 2 h. (A-F) IL-6 and steroidogenic 887 
genes mRNA levels were measured in ATC7 cells by RTqPCR, and GAPDH was used as a 888 
house-keeping gene. (G) Relative levels of phosphorylated CREB (pCREB) were measured 889 
in ATC7 cells by western immunoblotting, and data were normalized to vinculin. Data are the 890 
mean ±SEM (n=4/group) and are expressed as fold induction of untreated ATC7 cells; data 891 
were analyzed by three-way ANOVA followed by Fisher’s LSD post hoc test. *P<0.05; 892 
**P<0.01; ***P<0.001; ****P<0.0001 vs same treatment ATC7 or ATC7 cells co-cultured 893 
with THP1 cells at time 0; ^^P<0.01; ^^^P<0.01; ^^P̂<0.01 vs untreated ATC7 or ATC7 894 
cells co-cultured with THP1 cell at the same time-point. 895 
 896 
Supplementary Table 1. The sequence of forward and reverse primers used in the RTqPCR 897 
experiments. 898 
 899 
Supplementary Figure 1. Effect of LPS on IL-6 mRNA in ATC7 cells. ACT7 cells were 900 
treated with LPS (10 μg/mL) for 1, 6, 24 and 48 h. Relative levels of IL-6 mRNA were 901 
measured by RTqPCR and GAPDH was used as a house-keeping gene. Data are the mean ± 902 
SEM (n=3/group) and are expressed as fold induction of untreated ATC7 cells. Data were 903 













Supplementary Figure 2. Effect of IFNγ and LPS on IL-6 mRNA in ATC7 cells. ACT7 906 
cells were treated with LPS (10 μg/mL) and/or IFNγ (100u or 1000u) for 1 and 6 hours. 907 
Relative levels of IL-6 mRNA were measured by RTqPCR and GAPDH was used as a house-908 
keeping gene. Data are the mean ± SEM (n=3/group) and are expressed as fold induction of 909 
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• We have developed a novel co-culture model of adrenocortical tumour cell lines 
murine ATC7 cells and macrophages derived from THP1 monocytes to investigate 
the immune-steroidogenic adrenal cross-talk. 
 
• LPS stimulation of ATC7 cells co-cultured with THP1 cells increases IL-6 mRNA 
expression and reduces StAR and DAX-1 mRNA expression in a dose-dependent 
manner. 
 
• Cytokines treatment affects the levels of IL-6 and steroidogenic genes expression, and 
these effects are different in ATC7 cells co-cultured with THP1 and ATC7 alone. 
 
• Glucocorticoids can prevent the LPS induced IL-6 mRNA expression and 
steroidogenic gene in ATC7-THP1 cells in a dose-dependent manner. 
 
• ACTH induced adrenal IL-6 mRNA expression and steroidogenic genes activation are 
modulated by co-culture with THP1 cells. 
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